Co‐methylation network analysis of Psychosis in Alzheimer’s disease
Understanding molecular differences between AD and Psychosis at the genetic and epigenetic levels could guide us in discovering appropriate treatments for AD+P cases. To this end, we initiated a comprehensive, large sample-sized network analysis study based on genetic and epigenetic data.
Authors
- Julia Kofler (ORCID: https://orcid.org/0000-0003-4298-7328)
- Ali Torkamani (ORCID: https://orcid.org/0000-0003-0232-8053)
- Geir Selbæk (ORCID: https://orcid.org/0000-0001-6511-8219)
- Jennifer Imm (ORCID: https://orcid.org/0000-0002-8827-8669)
- Clive Ballard (ORCID: https://orcid.org/0000-0003-0022-5632)
- Jonathan S. Mill (ORCID: https://orcid.org/0000-0003-1115-3224)
- Luke Weymouth (ORCID: https://orcid.org/0000-0002-1168-6015)
- Sverre Bergh (ORCID: https://orcid.org/0000-0001-9593-2967)
- Katie Lunnon (ORCID: https://orcid.org/0000-0001-7570-6065)
- Ehsan Pishva
- Morteza P Kouhsar
- Adam R. Smith (ORCID: https://orcid.org/0000-0001-6495-2711)
- Robert A. Sweet (ORCID: https://orcid.org/0000-0001-9154-9709)
- Yehani Wedatilake (ORCID: https://orcid.org/0000-0002-9268-7385)
- Byron Creese (ORCID: https://orcid.org/0000-0001-6490-6037)
- Claudia Bredemeyer
Institutions
- Oslo University Hospital (NO)
- Scripps Institution of Oceanography (US)
- University of Pittsburgh (US)
- Innlandet Hospital Trust (NO)
- University of Exeter (GB)
- Sykehuset i Vestfold (NO)
- Maastricht University (NL)
- Scripps (United States) (US)
- Brunel University of London (GB)
Publication Details
- Journal
- Alzheimer s & Dementia
- Published
- 2024-12-01
- DOI
- https://doi.org/10.1002/alz.088982
- Primary Topic
- Tryptophan and brain disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00